Eliezer Van Allen

Eliezer Van Allen

Harvard University

H-index: 98

North America-United States

About Eliezer Van Allen

Eliezer Van Allen, With an exceptional h-index of 98 and a recent h-index of 91 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Clinical computational oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Transposable element expression patterns in epigenetic mutational subtypes of clear cell renal cell carcinoma

Whole-slide multiplexed tissue imaging of prostate adenocarcinoma reveals distinct immune niches in high-versus low-grade tumors

Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions

Dissecting tumor-immune dynamics and radiotherapy response in oligometastatic prostate cancer.

Abstract P01: Impact of Germline and Somatic ATM Variants in Chronic Lymphocytic Leukemia (CLL): Clinical Implications and Response to PARP Inhibition

Responders to combination radiation and PD-1 blockade demonstrate reduced myeloid immunosuppression and enhanced interferon signaling in oligometastatic prostate cancer patients

PCO24-175: Immune Cell Dynamics After Radiotherapy for Oligometastatic Prostate Cancer

Rare germline structural variants increase risk for pediatric solid tumors

Eliezer Van Allen Information

University

Position

Dana-Farber Cancer Institute

Citations(all)

63155

Citations(since 2020)

48691

Cited By

33361

hIndex(all)

98

hIndex(since 2020)

91

i10Index(all)

233

i10Index(since 2020)

219

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Eliezer Van Allen Skills & Research Interests

Clinical computational oncology

Top articles of Eliezer Van Allen

Title

Journal

Author(s)

Publication Date

Transposable element expression patterns in epigenetic mutational subtypes of clear cell renal cell carcinoma

Cancer Research

Kevin Meli

Cora A Ricker

Sabrina Y Camp

Christof C Smith

Chris Labaki

...

2024/3/22

Whole-slide multiplexed tissue imaging of prostate adenocarcinoma reveals distinct immune niches in high-versus low-grade tumors

Cancer Research

Jeremiah Wala

Jia-Ren Lin

Brian Labadie

Daniel Peiffer

Andreánne Gagne

...

2024/3/22

Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions

William Lotter

Michael J Hassett

Nikolaus Schultz

Kenneth L Kehl

Eliezer M Van Allen

...

2024/5/1

Dissecting tumor-immune dynamics and radiotherapy response in oligometastatic prostate cancer.

Sophia C Kamran

Yukako Otani

David Qi

Isabella R Pompa

Richard Dzeng

...

2024/2/1

Abstract P01: Impact of Germline and Somatic ATM Variants in Chronic Lymphocytic Leukemia (CLL): Clinical Implications and Response to PARP Inhibition

Blood Cancer Discovery

Kiyomi Mashima

Nicholas Moore

Mariia Mikhaleva

Anna Petráčková

Samantha Shupe

...

2024/3/4

Responders to combination radiation and PD-1 blockade demonstrate reduced myeloid immunosuppression and enhanced interferon signaling in oligometastatic prostate cancer patients

Cancer Research

Zenghua Fan

David Y Oh

Anthony Wong

Katsuto Shinohara

Hao Nguyen

...

2024/3/22

PCO24-175: Immune Cell Dynamics After Radiotherapy for Oligometastatic Prostate Cancer

Journal of the National Comprehensive Cancer Network

Sophia C Kamran

Yukako Otani

David Qi

Isabella Rose Pompa

Richard Kuo Dzeng

...

2024/4/5

Rare germline structural variants increase risk for pediatric solid tumors

bioRxiv

Riaz Gillani

Ryan L Collins

Jett Crowdis

Amanda Garza

Jill K Jones

...

2024

Longitudinal whole exome sequencing of cell-free DNA in advanced bladder cancer.

Arvind Ravi

Ilana Epstein

Dory Freeman

Praful Ravi

Tim Coorens

...

2024/2/1

Dissecting tumor-immune interaction in response and resistance to immune checkpoint blockade in metastatic melanoma

Cancer Research

Giuseppe Tarantino

Yiwen He

Priyanka Solanky

Aaron Thorner

Tyler Aprati

...

2024/3/22

Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma

European Urology Open Science

Seung Hun Han

Sabrina Y Camp

Hoyin Chu

Ryan Collins

Riaz Gillani

...

2024/4/1

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for Immunotherapy of Cancer

Brandon M Huffman

Harshabad Singh

Lestat R Ali

Nora Horick

S Jennifer Wang

...

2024

Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.

Alok Tewari

Anis Hamid

Jiaming Huang

Caiwei Zhong

Wanling Xie

...

2024/2/1

Tumor-immune interactions and cisplatin resistance in localized muscle-invasive bladder cancer

Cancer Research

Filipe La Fuente De Carvalho

Jihyun Lee

Kevin Bi

Breanna Titchen

Konrad Stawiski

...

2024/3/22

Randomized phase II study evaluating the addition of pembrolizumab to radium-223 in metastatic castration-resistant prostate cancer

Atish Dipankar Choudhury

Lucia Kwak

Alexander Cheung

Abhishek Tripathi

Amanda Fredericks Pace

...

2021/2/20

Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).

Chris Labaki

Michel Alchoueiry

Kevin Bi

Long Zhang

Charbel Hobeika

...

2024/2/1

Historical perspective and future directions: computational science in immuno-oncology

Cora A Ricker

Kevin Meli

Eliezer M Van Allen

2024

Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with prostate cancer progression

Cancer Research

Aram Lyu

Zenghua Fan

Diamond Luong

Ali Setayesh

Alec Starzinski

...

2024/3/22

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Cancer Cell

Renée Maria Saliby

Chris Labaki

Tejas R Jammihal

Wanling Xie

Maxine Sun

...

2024/3/22

MP65-10 SINGLE-CELL ASSAY FOR TRANSPOSASE-ACCESSIBLE CHROMATIN SEQUENCING DEMONSTRATES ACCESSIBILITY OVERLYING GENE PROMOTER REGIONS FOR PREVIOUSLY ESTABLISHED BASAL CELL MARKERS

The Journal of Urology

Jillian Egan

Jihyun Lee

Sabrina Camp

Amanda Garza

Jihye Park

...

2024/5

See List of Professors in Eliezer Van Allen University(Harvard University)

Co-Authors

H-index: 82
Scott L. Carter

Scott L. Carter

Harvard University

H-index: 24
Eran Hodis

Eran Hodis

Harvard University

academic-engine